Luliconazole
Active ingredient: Luliconazole
In short: Luliconazole Cream, 1% is indicated for the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum and Epidermophyton floccosum.
What is Luliconazole used for?
Luliconazole Cream, 1% is indicated for the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum and Epidermophyton floccosum.
Luliconazole dosage
For topical use only. Luliconazole Cream, 1% is not for ophthalmic, oral, or intravaginal use.
•When treating interdigital tinea pedis, a thin layer of Luliconazole Cream, 1% should be applied to the affected area and approximately 1 inch of the immediate surrounding area(s) once daily for 2 weeks.
•When treating tinea cruris or tinea corporis, Luliconazole Cream, 1% should be applied to the affected area and approximately 1 inch of the immediate surrounding area(s) once daily for 1 week.
How to take Luliconazole — instructions & advice from the label
Advise the patient to read the FDA-approved patient labeling (Patient Information).
•Inform patients that Luliconazole Cream, 1% is for topical use only. Luliconazole Cream, 1% is not intended for intravaginal or ophthalmic use.
Distributed by:
Oceanside Pharmaceuticals, a division ofBausch Health US, LLCBridgewater, NJ 08807 USA
Manufactured by:
Bausch Health Companies Inc.Laval, Quebec H7L 4A8, CanadaU.S. Patent Numbers: 8,980,931; 9,012,484; 9,199,977 and 9,453,006
© 2020 Bausch Health Companies Inc. or its affiliates
9616403
Warnings & precautions
Do not take this medicine if: None.
Luliconazole side effects
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
In three Phase 3 clinical trials, 616 subjects were exposed to Luliconazole Cream, 1%: 305 with interdigital tinea pedis and 311 subjects with tinea cruris. Subjects with interdigital tinea pedis or tinea cruris applied Luliconazole Cream, 1% or vehicle cream once daily for 14 days or 7 days, respectively, to affected and adjacent areas. During clinical trials with Luliconazole Cream, 1%, the most common adverse reactions were application site reactions which occurred in less than 1% of subjects in both the Luliconazole and vehicle arms. Most adverse reactions were mild in severity.
A post-approval clinical trial was conducted in 75 subjects age 2 to <18 years old with tinea corporis. The adverse reactions in the Luliconazole Cream, 1% treated population were similar to the vehicle treated population.
The following adverse reactions have been identified during postmarketing use of luliconazole cream, 1%: contact dermatitis and cellulitis. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
Drug interactions
An in vivo study in adult subjects with moderate to severe interdigital tinea pedis and tinea cruris showed that Luliconazole Cream, 1% is mostly a weak inhibitor of CYP2C19. In a separate trial in adolescent subjects with tinea cruris, in vivo blood levels of Luliconazole Cream, 1%, were seen to approach those levels sufficient to show moderate inhibition of CYP2C19 .
About this medicine
Luliconazole Cream, 1% contains 1% luliconazole, an azole antifungal agent, in a white cream for topical application.
Luliconazole is (2E)-2-[(4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-imidazol-1-ylacetonitrile. Its structural formula is:
The molecular formula is C14H9Cl2N3S2 with a molecular weight of 354.28. Luliconazole is the R enantiomer and contains one chiral center. The double bond adjacent to the dithiolane group is in the E configuration.
Luliconazole Cream, 1% contains 10 mg of luliconazole per gram of cream in a vehicle consisting of benzyl alcohol, butylated hydroxytoluene, cetostearyl alcohol, isopropyl myristate, medium-chain triglycerides, methylparaben, polysorbate 60, propylene glycol, purified water, and sorbitan monostearate.
How it works: Luliconazole Cream, 1% is an azole antifungal . At therapeutic doses, Luliconazole Cream, 1% is not expected to prolong QTc to any clinically relevant extent. Luliconazole is the R enantiomer of a chiral molecule.
Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 7ccda3ba-9c98-468d-83c6-7f0cc7c88c33. Read the full official label on DailyMed.